Condition category
Mental and Behavioural Disorders
Date applied
17/02/2005
Date assigned
21/02/2005
Last edited
03/08/2007
Prospective/Retrospective
Retrospectively registered
Overall trial status
Completed
Recruitment status
No longer recruiting

Plain English Summary

Not provided at time of registration

Trial website

Contact information

Type

Scientific

Primary contact

Dr David Schriger

ORCID ID

Contact details

924 Westwood Blvd Suite 300
Los Angeles
CA
90024-2924
United States of America
+1 310 794 0593
schriger@ucla.edu

Additional identifiers

EudraCT number

ClinicalTrials.gov number

Protocol/serial number

N/A

Study information

Scientific title

Acronym

UCLA PRIME MD-2

Study hypothesis

Not provided at time of registration.

Ethics approval

Not provided at time of registration.

Study design

Randomised controlled trial

Primary study design

Interventional

Secondary study design

Randomised controlled trial

Trial setting

Hospitals

Trial type

Diagnostic

Patient information sheet

Condition

Depression, anxiety and other psychiatric conditions

Intervention

Patients take the computerized PRIME-MD in the ED waiting room. They are randomized to three groups: PRIME-MD results shared with no one, shared with the patient only, or shared with the patient and the treating ED physician.
Low cost/no cost psychiatric referral sheet made available in the ED.

Intervention type

Other

Phase

Not Specified

Drug names

Primary outcome measures

Not provided at time of registration.

Secondary outcome measures

Not provided at time of registration.

Overall trial start date

01/03/2002

Overall trial end date

01/09/2002

Reason abandoned

Eligibility

Participant inclusion criteria

ED patients who present with a somatic (non-psychiatric) complaint that is of long duration, is chronic, or is not of a severity to warrant emergency care.
Resident physicians in Emergency Medicine and their faculty.

Participant type

Patient

Age group

Not Specified

Gender

Not Specified

Target number of participants

Not provided at time of registration.

Participant exclusion criteria

Not provided at time of registration.

Recruitment start date

01/03/2002

Recruitment end date

01/09/2002

Locations

Countries of recruitment

United States of America

Trial participating centre

924 Westwood Blvd Suite 300
Los Angeles, CA
90024-2924
United States of America

Sponsor information

Organisation

University of California, Los Angeles (UCLA) (USA)

Sponsor details

924 Westwood Blvd Suite 300
Los Angeles
CA
90024 2924
United States of America

Sponsor type

University/education

Website

Funders

Funder type

Industry

Funder name

The Pfizer Corporation provided a $60,000 gift (not grant) in support of this research.

Alternative name(s)

Funding Body Type

Funding Body Subtype

Location

Results and Publications

Publication and dissemination plan

Not provided at time of registration

Intention to publish date

Participant level data

Not provided at time of registration

Results - basic reporting

Publication summary

Results in: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=15882462

Publication citations

  1. Results

    Schriger DL, Gibbons PS, Nezami WA, Langone CA, Failure of a patient-centered intervention to substantially increase the identification and referral for-treatment of ambulatory emergency department patients with occult psychiatric conditions: a randomized trial [ISRCTN61514736]., BMC Emerg Med, 2005, 5, 1, 2, doi: 10.1186/1471-227X-5-2.

Additional files

Editorial Notes